ERBB2 and neoplasm: Herein we report a case of a patient with metastatic HCC and large disease burden who was serendipitously found to have a very high ERBB2 copy number amplification by circulating tumor DNA (ctDNA) liquid biopsy, prompting us to perform confirmational testing and act on this actionable marker.